Pricing Log in Create free account

Decoy Therapeutics Inc (DCOY) vs HCW Biologics Inc. (HCWB)

Decoy Therapeutics Inc and HCW Biologics Inc. are both Biotechnology companies. Decoy Therapeutics Inc and HCW Biologics Inc. are of similar size ($2.9M and $2.8M). HCW Biologics Inc. has negative trailing earnings, so its P/E is not meaningful; Decoy Therapeutics Inc trades at 0.0×. HCW Biologics Inc. grew revenue faster over the last twelve months: 707.0% against −60.5%. HCW Biologics Inc. has the higher net margin (−329.4% vs −698.8%) and the lower return on invested capital (−36.2% vs 0.00%). Across the 17 metrics below, HCW Biologics Inc. leads on 11 and Decoy Therapeutics Inc on 6.

Valuation

Metric DCOY HCWB Biotechnology median
P/E 0.01 n/m 8.50
P/S 0.30 0.25 9.71
P/B 0.14 0.22 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.49 n/m 0.64
EV/Sales (3.48) 1.17 9.21
Earnings yield 15,691.12% (2,225.58%) (33.15%)
Free cash flow yield (1,677.54%) (752.91%) (25.50%)

Profitability

Metric DCOY HCWB Biotechnology median
Gross margin 10.57% 95.91% 65.16%
Operating margin (706.88%) (114.02%) 0.00%
Net margin (698.79%) (329.38%) 0.00%
Free cash flow margin (432.43%) (180.57%) 0.00%
Return on equity (827.77%) (600.32%) (56.36%)
Return on assets (278.04%) (79.52%) (48.04%)
Return on invested capital 0.00% (36.15%) 0.00%

Growth

Metric DCOY HCWB Biotechnology median
Revenue growth (TTM) (60.49%) 706.96% 6.02%
EPS growth (last fiscal year) (85.66%) 65.49% 30.26%
Revenue growth, 5-year CAGR 12.73% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DCOY HCWB Biotechnology median
Debt to equity 0.00 0.88 0.00
Current ratio 1.83 0.06 4.72
Net debt to EBITDA 0.85 (0.40) 0.96

Dividend

Metric DCOY HCWB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DCOY HCWB Biotechnology median
Market cap 2.93m 2.75m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack